Table 4: Distribution of patients according to the serological status of the source patient and the consulting patient.

Serology

HIV+

N (%)

HIV–

N (%)

Not done/unknown

N (%)

 Source person*

264 (44)

35 (5.8)

301 (50.2)

 Consulting patient**

14 (2.3)

571 (95.2)

15 (2.5)

*Source person: Person from whom the potentially contaminated biological product (professional AEB) comes or from whom the non-professional AEB comes; **Consulting patient: Person victim of AEB.